Highlights:
Orders grew by 2.5% to £342.2 million (2013: £334.0 million)
Revenue grew by 2.7% to £360.1 million (2013: £350.8 million); 4.3% on a constant currency basis
Adjusted profit before tax of £47.1 million (2013: £47.0 million)
Adjusted operating margin of 14.0% (2013: 14.1%), in line with 14 Cubed objectives
Adjusted EPS up 1.8% at 67.7 pence (2013: 66.5 pence)
Andor Technology acquisition integrating well and performing ahead of plan
Investment in R&D, up 11.2% to £27.9 million (2013: £25.1 million)
Proposed final dividend of 9.04 pence (2013: 8.15 pence), giving a total dividend for the year of 12.4 pence (2013: 11.2 pence)
Strategy seeks to exploit the convergence of the sciences which will enhance demand for nanotechnology tools
Jonathan Flint, Chief Executive of Oxford Instruments plc, said:
"The Group delivered another successful result, with orders, sales and profits all ahead of the prior year. We are very pleased to welcome Andor to Oxford Instruments and see the acquisition as an important part of the next phase of our growth.
We will continue to focus on developing innovative new products and growing market share in our core areas of physical science. In addition, we will seek to extend our reach into adjacent new markets by applying our tools and technologies to life science research and analysis.
This convergence of the sciences will enhance long term demand for our nanotechnology tools and enable us to reach a new set of customers working in the nano-bio arena."
